These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 28622093

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
    Alen MM, Dallmeier K, Balzarini J, Neyts J, Schols D.
    Antiviral Res; 2012 Dec; 96(3):280-7. PubMed ID: 23124109
    [Abstract] [Full Text] [Related]

  • 24. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S, Pilankatta R, Khanna N, Swaminathan S.
    Vaccine; 2009 Oct 09; 27(43):6011-21. PubMed ID: 19665609
    [Abstract] [Full Text] [Related]

  • 25. Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.
    Vervaeke P, Alen M, Noppen S, Schols D, Oreste P, Liekens S.
    PLoS One; 2013 Oct 09; 8(8):e74035. PubMed ID: 24015314
    [Abstract] [Full Text] [Related]

  • 26. Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy.
    Lai YC, Chuang YC, Chang CP, Lin YS, Perng GC, Wu HC, Hsieh SL, Yeh TM.
    Antiviral Res; 2018 Jul 09; 155():28-38. PubMed ID: 29752950
    [Abstract] [Full Text] [Related]

  • 27. Mass spectrometric analysis of host cell proteins interacting with dengue virus nonstructural protein 1 in dengue virus-infected HepG2 cells.
    Dechtawewat T, Paemanee A, Roytrakul S, Songprakhon P, Limjindaporn T, Yenchitsomanus PT, Saitornuang S, Puttikhunt C, Kasinrerk W, Malasit P, Noisakran S.
    Biochim Biophys Acta; 2016 Sep 09; 1864(9):1270-1280. PubMed ID: 27108190
    [Abstract] [Full Text] [Related]

  • 28. Oleic acid Enhances Dengue Virus But Not Dengue Virus-Like Particle Production from Mammalian Cells.
    Ramphan S, Suksathan S, Wikan N, Ounjai P, Boonthaworn K, Rimthong P, Kanjanapruthipong T, Worawichawong S, Jongkaewwattana A, Wongsiriroj N, Smith DR.
    Mol Biotechnol; 2017 Oct 09; 59(9-10):385-393. PubMed ID: 28791613
    [Abstract] [Full Text] [Related]

  • 29. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
    Budigi Y, Ong EZ, Robinson LN, Ong LC, Rowley KJ, Winnett A, Tan HC, Hobbie S, Shriver Z, Babcock GJ, Alonso S, Ooi EE.
    PLoS Negl Trop Dis; 2018 Feb 09; 12(2):e0006209. PubMed ID: 29425203
    [Abstract] [Full Text] [Related]

  • 30. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry.
    Gao F, Duan X, Lu X, Liu Y, Zheng L, Ding Z, Li J.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):952-7. PubMed ID: 19962368
    [Abstract] [Full Text] [Related]

  • 31. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U, Tyagi P, Swaminathan S, Khanna N.
    Vaccine; 2013 Jan 30; 31(6):873-8. PubMed ID: 23261049
    [Abstract] [Full Text] [Related]

  • 32. Dengue virus infection of SK Hep1 cells: inhibition of in vitro angiogenesis and altered cytomorphology by expressed viral envelope glycoprotein.
    Basu A, Jain P, Sarkar P, Gangodkar S, Deshpande D, Ganti K, Shetty S, Ghosh K.
    FEMS Immunol Med Microbiol; 2011 Jul 30; 62(2):140-7. PubMed ID: 21332827
    [Abstract] [Full Text] [Related]

  • 33. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
    Abd-Jamil J, Cheah CY, AbuBakar S.
    Protein Eng Des Sel; 2008 Oct 30; 21(10):605-11. PubMed ID: 18669522
    [Abstract] [Full Text] [Related]

  • 34. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A, Ngwe Tun MM, Moi ML, Sakurai A, Ishikawa M, Kuno S, Ueno R, Morita K, Akahata W.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28956764
    [Abstract] [Full Text] [Related]

  • 35. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K, Gromowski GD, Li L, Schuh AJ, Lee JC, Barrett AD.
    Virology; 2009 Feb 05; 384(1):16-20. PubMed ID: 19101005
    [Abstract] [Full Text] [Related]

  • 36. Naturally mutated envelope protein domain I of Chinese B dengue virus attenuated human dendritic cell maturation.
    Li J, Zhang X, Zuo L, Shang Z, Sun R.
    Int Immunopharmacol; 2012 Dec 05; 14(4):683-9. PubMed ID: 23026443
    [Abstract] [Full Text] [Related]

  • 37. Targeting heat shock factor 1 as an antiviral strategy against dengue virus replication in vitro and in vivo.
    Tsai TT, Chen CL, Tsai CC, Lin CF.
    Antiviral Res; 2017 Sep 05; 145():44-53. PubMed ID: 28733114
    [Abstract] [Full Text] [Related]

  • 38. Thrombocytopenia in dengue infection: mechanisms and a potential application.
    Khazali AS, Hadrawi WH, Ibrahim F, Othman S, Nor Rashid N.
    Expert Rev Mol Med; 2024 Oct 14; 26():e26. PubMed ID: 39397710
    [Abstract] [Full Text] [Related]

  • 39. Suppression of µ1 subunit of the adaptor protein complex 2 reduces dengue virus release.
    Tongmuang N, Yasamut U, Noisakran S, Sreekanth GP, Yenchitsomanus PT, Limjindaporn T.
    Virus Genes; 2020 Feb 14; 56(1):27-36. PubMed ID: 31720911
    [Abstract] [Full Text] [Related]

  • 40. Dengue virus utilizes calcium modulating cyclophilin-binding ligand to subvert apoptosis.
    Li J, Huang R, Liao W, Chen Z, Zhang S, Huang R.
    Biochem Biophys Res Commun; 2012 Feb 24; 418(4):622-7. PubMed ID: 22281498
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.